☰

Andy H. Barnett - Publications

Affiliations: 
Auburn University, Auburn, AL, United States 
Area:
General Economics, Energy
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Brod M, Pfeiffer KM, Barnett AH, Berntorp K, Vilsbøll T, Weissenberger B. Perceptions of diabetes control among people with type 2 diabetes treated with basal insulin in Sweden, Switzerland, and the United Kingdom. Current Medical Research and Opinion. 1-30. PMID 27263866 DOI: 10.1080/03007995.2016.1198311  0.314
2015 Brod M, Fisher C, Barnett A, Berntorp K, Vilsbøll T, Weissenberger B. Defining uncontrolled diabetes from the patient Perspective: A four-country study in People with type-2 Diabetes On Basal Insulin Value in Health. 18: A66. DOI: 10.1016/J.JVAL.2015.03.384  0.335
2014 Jahagirdar V, Barnett AH. Empagliflozin for the treatment of type 2 diabetes. Expert Opinion On Pharmacotherapy. 15: 2429-41. PMID 25301180 DOI: 10.1517/14656566.2014.966078  0.301
2013 Barnett AH, Brice R, Hanif W, James J, Langerman H. Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents. Current Medical Research and Opinion. 29: 1503-13. PMID 23952328 DOI: 10.1185/03007995.2013.834250  0.326
2013 Barnett AH, Charbonnel B, Li J, Donovan M, Fleming D, Iqbal N. Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy. Clinical Drug Investigation. 33: 707-17. PMID 23949898 DOI: 10.1007/s40261-013-0107-8  0.308
2011 Lloyd A, Nafees B, Barnett AH, Heller S, Ploug UJ, Lammert M, Bøgelund M. Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus. Clinical Therapeutics. 33: 1258-67. PMID 21862132 DOI: 10.1016/j.clinthera.2011.07.017  0.321
2011 Hassanein M, Hanif W, Malik W, Kamal A, Geransar P, Lister N, Andrews C, Barnett A. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. Current Medical Research and Opinion. 27: 1367-74. PMID 21568833 DOI: 10.1185/03007995.2011.579951  0.301
2011 Diosdado MA, Barnett A. [The major challenge of daily glycemic control in patients with type 2 diabetes mellitus. Introduction]. Medicina Clinica. 1. PMID 21420529 DOI: 10.1016/S0025-7753(10)70024-5  0.306
2010 Barnett AH. Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy. Current Medical Research and Opinion. 26: 1333-42. PMID 20370379 DOI: 10.1185/03007991003738063  0.307
2009 Palalau AI, Tahrani AA, Piya MK, Barnett AH. DPP-4 inhibitors in clinical practice. Postgraduate Medicine. 121: 70-100. PMID 19940419 DOI: 10.3810/pgm.2009.11.2079  0.305
2006 Barnett AH, Bellary S. Novel metabolic drugs for the management of type 2 diabetes Practical Diabetes International. 23: 129-134. DOI: 10.1002/pdi.920  0.301
2004 Barnett AH. Treating to goal: challenges of current management. European Journal of Endocrinology. T3-7; discussion T29. PMID 15487977 DOI: 10.1530/EJE.0.151T003  0.327
2003 Tica V, Hanif MW, Andersson A, Valsamakis G, Barnett AH, Kumar S, Sanjeevi CB. Frequency of latent autoimmune diabetes in adults in Asian patients diagnosed as type 2 diabetes in Birmingham, United Kingdom. Annals of the New York Academy of Sciences. 1005: 356-8. PMID 14679091 DOI: 10.1196/ANNALS.1288.058  0.308
2003 Barnett AH, Grant PJ, Hitman GA, Mather H, Pawa M, Robertson L, Trelfa A. Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients. Diabetic Medicine : a Journal of the British Diabetic Association. 20: 387-93. PMID 12752488 DOI: 10.1046/j.1464-5491.2003.00925.x  0.301
2001 Kelly MA, Chan JC, Heward J, Mijovic CH, Zimmet PZ, Yeung VT, Cockram C, Barnett AH. HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population. Diabetic Medicine : a Journal of the British Diabetic Association. 18: 22-8. PMID 11168337 DOI: 10.1046/j.1464-5491.2001.00400.x  0.316
2000 Barnett AH, Kaserman DL. Comment on 'The Shortage in Market-Inalienable Human Organs' Faulty Analysis of a Failed Policy The American Journal of Economics and Sociology. 59: 335-349. DOI: 10.1111/1536-7150.00030  0.314
1999 Dyer PH, Chowdhury TA, Dronsfield MJ, Dunger D, Barnett AH, Bain SC. The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patients. Diabetologia. 42: 1030-1. PMID 10491768 DOI: 10.1007/s001250051266  0.3
1999 Chowdhury TA, Dyer PH, Mijovic CH, Dunger DB, Barnett AH, Bain SC. Human leucocyte antigen and insulin gene regions and nephropathy in type I diabetes. Diabetologia. 42: 1017-20. PMID 10491764 DOI: 10.1007/s001250051262  0.318
1997 Chowdhury TA, Dyer PH, Kumar S, Gough SC, Gibson SP, Rowe BR, Smith PR, Dronsfield MJ, Marshall SM, Mackin P, Dean JD, Morris PJ, Davies S, Dunger DB, Boulton AJ, ... Barnett AH, et al. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabetic Medicine : a Journal of the British Diabetic Association. 14: 837-40. PMID 9371475 DOI: 10.1002/(SICI)1096-9136(199710)14:10<837::AID-DIA463>3.0.CO;2-V  0.302
1996 Chowdhury TA, Dronsfield MJ, Kumar S, Gough SL, Gibson SP, Khatoon A, MacDonald F, Rowe BR, Dunger DB, Dean JD, Davies SJ, Webber J, Smith PR, Mackin P, Marshall SM, ... ... Barnett AH, et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia. 39: 1108-14. PMID 8877296 DOI: 10.1007/Bf00400661  0.303
1996 Chowdhury TA, Kumar S, Barnett AH, Bain SC. Nephropathy in type 1 diabetes: the role of genetic factors. Diabetic Medicine : a Journal of the British Diabetic Association. 12: 1059-67. PMID 8750215 DOI: 10.1111/j.1464-5491.1995.tb00422.x  0.304
1996 Barnett AH, Kaserman DL, Blair RD. A market for organs Society. 33: 8-17. DOI: 10.1007/Bf02701857  0.313
1994 Penny MA, Mijovic CH, Cavan DA, Jacobs KH, Jenkins D, Fletcher J, Barnett AH. An investigation of the association between HLA-DQ heterodimers and type 1 (insulin-dependent) diabetes mellitus in five racial groups. Human Immunology. 38: 179-83. PMID 8106274 DOI: 10.1016/0198-8859(93)90537-B  0.307
1993 Barnett AH, Beard TR, Kaserman DL. The medical community's opposition to organ markets: Ethics or economics? Review of Industrial Organization. 8: 669-678. DOI: 10.1007/Bf01024291  0.311
1991 Barnett AH. Some recent advances in non-communicable diseases in the tropics. 2. Diabetes mellitus in the tropics. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85: 327-31. PMID 1949132 DOI: 10.1016/0035-9203(91)90278-7  0.305
1989 Thornalley PJ, Hooper NI, Jennings PE, Florkowski CM, Jones AF, Lunec J, Barnett AH. The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Research and Clinical Practice. 7: 115-20. PMID 2776650 DOI: 10.1016/0168-8227(89)90101-0  0.3
1989 Odugbesan O, Rowe B, Fletcher J, Walford S, Barnett AH. Diabetes in the UK West indian community: the Wolverhampton survey. Diabetic Medicine : a Journal of the British Diabetic Association. 6: 48-52. PMID 2522374 DOI: 10.1111/j.1464-5491.1989.tb01138.x  0.319
1987 Odugbesan O, Fletcher J, Mijovic C, Mackay E, Bradwell AR, Barnett AH. The HLA-D associations of type 1 (insulin-dependent) diabetes in Punjabi Asians in the United Kingdom. Diabetologia. 30: 618-21. PMID 3653560 DOI: 10.1007/BF00277317  0.319
1986 Barnett AH, Pyke DA. The genetics of diabetic complications Clinics in Endocrinology and Metabolism. 15: 715-726. PMID 3536196 DOI: 10.1016/S0300-595X(86)80070-6  0.316
1986 Mijovic C, Fletcher JA, Bradwell AR, Barnett AH. Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: Evidence for an immunogenetic predisposition British Medical Journal (Clinical Research Ed.). 292: 433-435. PMID 3081112 DOI: 10.1136/bmj.292.6518.433  0.318
1986 Odugbesan O, Mijovic C, Saunders A, Mackay E, Fletcher J, Bradwell A, Barnett A. HLA-DR Types and Autoimmunity in Insulin Dependent Diabetics of Asian Origin in the West Midlands Clinical Science. 71: 59P-60P. DOI: 10.1042/CS071059PC  0.301
1985 Barnett A, Armstrong S, Chisholm I, Letherdale B, Wakelin K. Specific Thromboxane Synthetase Inhibition and Diabetic Retinopathy in Insulin Dependent Diabetics Clinical Science. 68: 47P-47P. DOI: 10.1042/CS068047P  0.311
1983 Barnett AH, Spiliopoulos AJ, Pyke DA, Stubbs WA, Rowold E, Hoffmann P, Faller A, Kilo C, Miller JP, Williamson JR. Muscle capillary basement membrane in identical twins discordant for insulin-dependent diabetes. Diabetes. 32: 557-60. PMID 6685074 DOI: 10.2337/diab.32.6.557  0.319
1981 Nikolaides K, Barnett AH, Spiliopoulos AJ, Watkins PJ. West Indian diabetic population of a large inner city diabetic clinic. British Medical Journal (Clinical Research Ed.). 283: 1374-5. PMID 6797550 DOI: 10.1136/bmj.283.6303.1374  0.307
Show low-probability matches.